The modifying influence of HLA class II DQB1∗06:02 on the Streptococcus and clinical phenotype correlation among anti-Ro+ mothers of children with neonatal lupus

• Robert M. Clancy,
• Carla J. Guthridge,
• Miranda C. Marion,
• Joel Guthridge,
• Timothy D. Howard,
• Peter M. Izmirly,
• Mala Masson,
• Jill P. Buyon,
• Judith A. James,
• Carl D. Langefeld

Affiliations

Robert M. Clancy

Department of Medicine, Division of Rheumatology, NYU Grossman School of Medicine, New York, NY 10016, USA; Corresponding author.

Carla J. Guthridge

Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA

Miranda C. Marion

Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston–Salem, NC 27101, USA; Center for Precision Medicine, Wake Forest School of Medicine, Winston–Salem, NC 27101, USA

Joel Guthridge

Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA

Timothy D. Howard

Center for Precision Medicine, Wake Forest School of Medicine, Winston–Salem, NC 27101, USA; Department of Biochemistry, Wake Forest School of Medicine, Winston–Salem, NC 27101, USA

Peter M. Izmirly

Department of Medicine, Division of Rheumatology, NYU Grossman School of Medicine, New York, NY 10016, USA

Mala Masson

Department of Medicine, Division of Rheumatology, NYU Grossman School of Medicine, New York, NY 10016, USA

Jill P. Buyon

Department of Medicine, Division of Rheumatology, NYU Grossman School of Medicine, New York, NY 10016, USA

Judith A. James

Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA

Carl D. Langefeld

Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston–Salem, NC 27101, USA; Center for Precision Medicine, Wake Forest School of Medicine, Winston–Salem, NC 27101, USA